Pneumonia Vaccine Market by Type (Pneumococcal Polysaccharide Vaccine (PPSV23), Pneumococcal Conjugate Vaccine (PCV13)), Patient Type, Distribution Channel, and Geography - Global Industry Analysis, Opportunities and Forecast up to 2028

Pneumonia Vaccine Market Size

The Pneumonia Vaccine market size was valued at $7.70 billion in 2022 and is projected to reach $10.62 billion by 2028, growing at a CAGR of 5.5% during the forecast period.

Pneumonia Vaccine Market Overview

A pneumonia vaccine is a type of immunization designed to protect against pneumonia, a serious respiratory infection caused by bacteria, viruses, or fungi. There are two main types of pneumonia vaccines: the pneumococcal conjugate vaccine (PCV) and the pneumococcal polysaccharide vaccine (PPSV). PCV is typically administered to infants and young children to protect against pneumococcal infections, which are a common cause of pneumonia in this age group. PPSV is recommended for adults over the age of 65 and individuals with certain medical conditions or weakened immune systems. Both vaccines work by stimulating the body's immune system to produce antibodies against specific strains of bacteria that can cause pneumonia, thereby reducing the risk of infection and its potentially severe complications, such as difficulty breathing, hospitalization, and even death. Pneumonia vaccines are an important tool in public health efforts to prevent and control respiratory infections, particularly among vulnerable populations, such as young children, the elderly, and individuals with underlying health conditions. Regular vaccination against pneumonia is recommended by healthcare professionals as part of routine immunization schedules to help protect individuals and communities from this common and potentially life-threatening illness.

Pneumonia Vaccine Market Dynamics

The market dynamics analyzed in this market research report encapsulate a multifaceted interplay of drivers and constraints that significantly shape the landscape of the Pneumonia Vaccine Market. The comprehensive analysis of both drivers and constraints enables a nuanced understanding of the market's dynamics, empowering businesses and stakeholders to make informed decisions in navigating the complexities of the market.

Pneumonia Vaccine Market Scope

The report “Global Pneumonia Vaccine Market: Industry Analysis, Opportunities and Forecast up to 2028” by Diligence Insights provides a detailed analysis of the present market and future outlook with market estimates and forecasts for all specified segments, encompassing both global and regional perspectives as outlined within the research framework. The study includes historical market data for the years 2020, 2021 and offers revenue estimations for 2022, and project forecasts spanning from 2023 to 2028. It places significant emphasis on the examination of market trends, key industry participants, supply chain developments, technological advancements, pivotal milestones, and prospective strategies. Comprehensive market assessments are carried out across major geographic regions, including North America, Europe, Asia Pacific, South America, and Middle East & Africa. As such, this report constitutes a valuable resource for current industry stakeholders, newcomers to the field, and potential investors.

The study offers an in-depth market analysis, drawing insights from industry experts across the value chain. A special focus has been made on 25 countries, including the United States, Canada, Mexico, the United Kingdom, Germany, Spain, France, Italy, China, Brazil, Saudi Arabia, and South Africa, among others. The market data has been meticulously collected through extensive primary interviews and comprehensive secondary research. Market size determination is rooted in the revenue generated from sales across all the specified segments and sub-segments as defined within the research scope. The market sizing analysis includes both top-down and bottom-up approaches for data validation and accuracy measures.

Market Segmentation:

The research report includes in-depth coverage of the industry analysis with size, share, and forecast for the below segments:

Global Pneumonia Vaccine Market by, Type

·        Pneumococcal Polysaccharide Vaccine (PPSV23)

·        Pneumococcal Conjugate Vaccine (PCV13)

Global Pneumonia Vaccine Market by, Patient Type

·        Adult Patients

·        Pediatric Patients

Global Pneumonia Vaccine Market by, Distribution Channel

·        Hospitals

·        Clinics

·        Other Distribution Channels

Global Pneumonia Vaccine Market by, Geography

·        North America (The United States, Canada, Mexico), Market Estimates, Forecast & Opportunity Analysis.

·        Europe (Germany, France, UK, Italy, Spain, Rest of Europe), Market Estimates, Forecast & Opportunity Analysis

·        Asia Pacific (China, Japan, India, South Korea, Australia, New Zealand, Rest of Asia Pacific), Market Estimates, Forecast & Opportunity Analysis

·        South America (Brazil, Argentina, Chile, Rest of South America), Market Estimates, Forecast & Opportunity Analysis

·        Middle East & Africa (UAE, Saudi Arabia, Qatar, Iran, South Africa, Rest of Middle East & Africa), Market Estimates, Forecast & Opportunity Analysis.

Key Players Profiled in this Research Report include:

·        Serum Institute of India Private Limited

·        Sanofi Pasteur

·        Pfizer Inc

·        Panacea Drugs Pvt. Ltd

·        Merck & Co., Inc

·        GlaxoSmithKline plc

·        Emergent Biosolutions, Inc.

·        CSL Limited

·        Biological E Limited

·        Astellas Pharma Inc.

What can be explored with this research report?

·        Understand global Pneumonia Vaccine Market analysis, trends, and forecast to 2028.

·        Understand analysis of the Pneumonia Vaccine Market structure by identifying various segments and sub-segments of the market.

·        Understand revenue forecast and strategic analysis concerning industry trends and contribution to the overall Pneumonia Vaccine Market.

·        Understand the revenue forecast of the Pneumonia Vaccine Market for North America, Europe, Asia-Pacific, South America, and Middle East & Africa.

·        Identification of major market trends, factors driving, restraining, threatening, and providing opportunities for the Pneumonia Vaccine Market growth.

·        Analyzing opportunities by identification of high-growth segments/revenue pockets in the Pneumonia Vaccine Market.

·        Understand major player profiles in the Pneumonia Vaccine Market and analyze their business strategies.

·        Understand competitive developments such as joint ventures, alliances, mergers and acquisitions, and new product launches in the Pneumonia Vaccine Market.

Table Of Content

1 Market Introduction 
 1.1 Market Definition 
 1.2 Research Scope and Segmentation 
 1.3 Stakeholders 
 1.4 List of Abbreviations 
 
2 Executive Summary 
 
3 Research Methodology 
 3.1 Identification of Data 
 3.2 Evaluation of Market Dynamics 
 3.3 Collaboration of Data 
 3.4 Verification and Analysis 
 3.5 Research Approach 
 3.6 Data Sources and Assumptions 
 
4 Market Dynamics 
 4.1 Market Drivers 
 4.2 Market Restraints 
 4.3 Market Opportunities 
 4.4 Market Challenges 
 4.5 Impact of COVID-19 on the Pneumonia Vaccine Market 
 
5 Porter's Five Force Analysis 
 5.1 Bargaining Power of Suppliers 
 5.2 Bargaining Power of Buyers 
 5.3 Threat of New Entrants 
 5.4 Threat of Substitutes 
 5.5 Competitive Rivalry in the Market 
 
6 Global Pneumonia Vaccine Market by, Type 
 6.1 Overview 
 6.2 Pneumococcal Polysaccharide Vaccine (PPSV23) 
 6.3 Pneumococcal Conjugate Vaccine (PCV13) 
 
7 Global Pneumonia Vaccine Market by, Patient Type 
 7.1 Overview 
 7.2 Adult Patients 
 7.3 Pediatric Patients 
 
8 Global Pneumonia Vaccine Market by, Distribution Channel 
 8.1 Overview 
 8.2 Hospitals 
 8.3 Clinics 
 8.4 Other Distribution Channels 
 
9 Global Pneumonia Vaccine Market by, Geography 
 9.1 Overview 
 9.2 North America 
 9.2.1 US 
 9.2.2 Canada 
 9.2.3 Mexico 
 9.3 Europe 
 9.3.1 Germany 
 9.3.2 France 
 9.3.3 UK 
 9.3.4 Italy 
 9.3.5 Spain 
 9.3.6 Rest of Europe 
 9.4 Asia Pacific 
 9.4.1 China 
 9.4.2 Japan 
 9.4.3 India 
 9.4.4 South Korea 
 9.4.5 Australia 
 9.4.6 New Zealand 
 9.4.7 Rest of Asia Pacific 
 9.5 South America 
 9.5.1 Brazil 
 9.5.2 Argentina 
 9.5.3 Chile 
 9.5.4 Rest of South America 
 9.6 Middle East & Africa 
 9.6.1 UAE 
 9.6.2 Saudi Arabia 
 9.6.3 Qatar 
 9.6.4 Iran 
 9.6.5 South Africa 
 9.6.6 Rest of Middle East & Africa 
 
10 Key Developments 
 
11 Company Profiling 
 11.1 Serum Institute of India Private Limited  
 11.1.1 Business Overview 
 11.1.2 Product/Service Offering 
 11.1.3 Financial Overview 
 11.1.4 SWOT Analysis 
 11.1.5 Key Activities 
 11.2 Sanofi Pasteur  
 11.3 Pfizer Inc 
 11.4 Panacea Drugs Pvt. Ltd 
 11.5 Merck & Co., Inc 
 11.6 GlaxoSmithKline plc 
 11.7 Emergent Biosolutions, Inc.  
 11.8 CSL Limited  
 11.9 Biological E Limited 
 11.10 Astellas Pharma Inc.